Fig. 6

Clinical application of the ICD-risk scores. (A) Correlation analysis of ICD- risk scores and expression of various types of immune cells (B cell, CD8 T cell, CD4 T cell, Macrophages-M2, NK cell and Treg cells); (B) Correlation of ICD-risk genes and clinical information; (C) miRNA-gene and transcription factor-gene regulatory network was constructed to initially explore the pathogenesis of acute myeloid leukemia; (D) Different comparisons of number of patients in morphology classification, age, sex, cytogenetics and survival events between subgroups; (E) Identification of the targeted drugs for ICD prognosis genes; (F) Subgroup survival analysis